High resolution magic angle spinning NMR spectroscopy used to investigate the ability of drugs to bind to synthetic melanin

Pigment Cell Research

Volumn 18, Issue 1, 2005, Pages 49-54

  Borel, Michèle ^a   Lafarge, David ^a   Moreau, Marie France ^a   Bayle, Martine ^a   Audin, Laurent ^a   Moins, Nicole ^a   Madelmont, Jean Claude ^a  

^a INSERM   (France)

Author keywords

Drug melanin interactions; High resolution magic angle NMR spectroscopy; Insoluble melanin; Line broadening

Indexed keywords

4 IODOHIPPURATE SODIUM; ACETYLCHOLINE; BENZAMIDE DERIVATIVE; DEUTERIUM; HIPPURIC ACID; IODOBENZAMIDE DERIVATIVE; MELANIN; METHANOL; N (2 DIETHYLAMINOETHYL) 4 IODOBENZAMIDE; N (2 DIMETHYLAMINOETHYL) 4 HALOGENOBENZAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; DISSOCIATION CONSTANT; DRUG BINDING; DRUG STRUCTURE; IN VITRO STUDY; MAGNETISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ELECTRON SPIN RESONANCE SPECTROSCOPY; IODOBENZENES; MELANINS;

EID: 12844253098     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0749.2004.00210.x     Document Type: Article

References (40)

1. Albrand, J.P., Birdsall, B., Feeney, J., Roberts, G.C.K., and Burgen, A.S.V. (1979). Theuse of transferred nuclear Overhauser effects in the study of the conformations of small molecules bound to proteins. Int. J. Biol. Macromol. 7, 37-41.
2. Balaram, P., Bothner-By, A.A., and Dadok, J. (1972). Negative nuclear Overhauser effects as probes of macromolecular structure. J. Am. Chem. Soc. 94, 4015-4035.
3. Balaram, P., Bothner-By, A.A., and Breslow, E. (1973). Nuclear magnetic resonance studies of the interaction of peptides and hormones with bovine neurophysin. Biochemistry 12, 4695-4704.
4. Bertini, I., and Luchinat, C. (1996). NMR of Paramagnetic Substances in Coordination Chemistry, vol. 150 (New York: Elsevier).
5. Bridelli, M.G., Trampellini, D., and Zecca, L. (1999). The structure of neuromelanin and its iron binding site studied by infrared spectroscopy. FEBS Lett. 457, 18-22.
6. Chehade, F., De Labriolle-Vaylet, C., Michelot, J., Moins, N., Moreau, M.F., Hindie, E., Papon, J., Escaig, F., Galie, P., and Veyre, A. (2001). A Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: a study by secondary ion mass spectroscopy. Cell. Mol. Biol. 47, 529-534.
7. Coderre, J.A., Packer, S., Fairchild, R.G., Greenberg, D., Laster, B., Micca, P., and Fand, I. (1986). Iodothiouracil as a melanoma localizing agent. J. Nucl. Med. 17, 1157-1164.
8. Cohen, M.B., Saxton, R.E., Lake, R.R., Cagle, R., Graham, L.S., Nizze, A., Yamada, L.S., Gan, M., Bronca, G., Greenwell, K. et al. (1988). Detection of malignant melanoma with iodine-123-iodoamphetamine. J. Nucl. Med. 29, 1200-1206.
9. Duff, G.A., Roberts, J.E., and Foster, N. (1988). Analysis of the structure of synthetic and natural melanins by solid-phase NMR. Biochemistry 27, 7112-7116.
10. Dwek, RA. (1973). Nuclear Magnetic Resonance in Biochemistry: Applications to Enzyme Systems (Oxford: Clarendon Press).
11. Elbayed, K., Bourdonneau, M., Furrer, J., Richert, T., Raya, J., Hirschinger, J., and Piotto, M. (1999). Origin of the residual NMR linewidth of a peptide bound to a resin under magic angle spinning. J. Magn. Reson. 136, 127-129.
12. Enochs, WS, Petherick, P, Bogdanova, A, Mohr, U, and Weissleder, R. (1997). Paramagnetic metal scavenging by melanin. Magn. Reson. Imaging Radiol. 204, 417-423.
13. Hall, H.I., Jamison, P., Fulton, J.P., Clutter, G., Roffers, S., and Parrish, P. (2003). Reporting cutaneous melanoma to cancer registries in the United States. J. Am. Acad. Dermatol. 49, 624-630.
14. 13C solid-state NMR study of the structure and auto-oxidation process of natural and synthetic melanins. Biochim. Biophys. Acta. 1204, 19-27.
15. Kalk, A., Berendsen, J.C. (1976). Proton magnetic relaxation and spin diffusion in proteins. J. Magn. Reson. 24, 343-366.
16. Labarre, P., Papon, J., Moreau, M.F., Moins, N., Veyre, A., and Madelmont, J.C. (1999). Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multiwire proportional counting. Eur. J. Nucl. Med. 26, 494.
17. Labarre, P., Papon, J., Moreau, M.F., Moins, N., Bayle, M., Veyre, A., and Madelmont, J.C. (2002). Melanin affinity of N-(2-diethylaminoethyl)-4- iodobenzamide, an effective melanoma imaging agent. Melanoma Res. 12, 115-121.
18. 123l]iodoquinoline. J. Nucl. Med. 25, 800-804.
19. Larson, B. (1993). Interaction between chemicals and melanin. Pigment Cell Res. 6, 127-133.
20. Larson, B., and Tjälve, H. (1979). Studies on the mechanism of drug-binding to melanin. Biochem. Pharmacol. 28, 1181-1187.
21. Lippens, G., Bourdonneau, M., Dhalluin, C., Warrass, R., Richert, T., Seetharaman, C., Boutillon, C., and Piotto, M. (1999). Study of compounds attached to solid supports using high resolution magic angle spinning NMR. Curr. Org. Chem. 3, 147-169.
22. Liu, Y., and Simon, J.D. (2003). Isolation and biophysical studies of natural eumelanins: applications of imaging technologies and ultrafast spectroscopy. Pigment Cell Res. 16, 606-618.
23. London, R.E. (2002). Chemical-shift and linewidth characterises of reversibly bound ligands. J. Magn. Reson. A 104, 190-196.
24. Lowrey, A.H., Famini, G.R., Loumbev, V., Wilson, L.Y., and Tosk, M. (1997). Modeling drug-melanin interaction with theoretical linear solvation energy relationships. Pigment cell Res. 10, 251-256.
25. McKinnon, J.G., Yu, X.Q., McCarty, W.H., and Thompson, J.F. (2003). Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales central Cancer Registry and the Sydney Melanoma Unit. Cancer 98, 1223-1231.
26. Michelot, J.M., Moreau, M.F., Labarre, P., Madelmont, J.C., Veyre, A., Papon, J., Parry, D., Bonafous, J., Boire, J.Y., Desplanches, G. et al. (1991). Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma. J. Nucl. Med. 32, 1573-1580.
27. Michelot, J., Moreau, M.F., Veyre, A., Bonafous, J., Bacin, F., Madelmont, J.C., Bussiere, F., Souteyrand, P., Mauclaire, L., Chossat, F. et al. (1993). Phase II scintigraphic clinical trial of malignant melanoma and metastases with 123 iodine N-(2-diethylaminoethyl)-4-iodobenzamide. J. Nucl. Med. 34, 1260-1266.
28. Miller, J., Witzemann, V., Quast, U., and Raftery, M.A. (1979). Proton magnetic resonance studies of cholinergic ligand binding to the acetylcholine receptor in its membrane environment. Proc. Natl Acad. Sci. U S A 76, 3580-3584.
29. Moins, N., Papon, J., Seguin, H., Gardette, D., Moreau, M.F., Labarre, P., Bayle, M., Michelot, J., Gramain, J.C., Madelmont, J.C. et al. (2001). Synthesis, characterization and comparative biodistribution study of a new series of p-Iodine-125 benzamides as potential melanoma imaging agents. Nucl. Med. Biol. 28, 799-808.
30. Moins, N., D'Incan, M., Bonafous, J., Bacin, F., Labarre, P., Moreau, M.F., Mestas, D., Noirault, E., Chossat, F., Berthommier, E. et al. (2002). 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging. Eur. J. Nucl. Med. 29, 1478-1484.
31. Moreau, M.F., Michelot, J., Papon, J., Bayle, M., Labarre, P., Madelmont, J.C., Parry, D., Boire, J.Y., Moins, N., Seguin, H. et al. (1995). Synthesis, radiolabeling and preliminary evaluation in mice of some (N-Diethylaminoethyl)- 4-iodobenzamide derivatives as melanoma imaging agents. Nucl. Med. Biol. 22, 737-747.
32. Ni, F. (1994). Recent developments in transferred NOE methods. Progr. NMR Spectrosc. 26, 517-606.
33. Potts, A.M. (1964). The reaction of uveal pigment in vitro with polycyclic compounds. Invest. Ophthalmol. 3, 410.
34. Prota, G. (2000). Melanins, melanogenesis and melanocytes: looking at their functional significance from the chemist's viewpoint. Pigment Cell Res. 13, 283-293.
35. Raghavan, P.V., Zane, P.A., and Tripp, S.L. (1990). Calculation of drug-melanin binding energy using molecular modeling. Experientia 46, 77-79.
36. Rutkowski, P., Nowecki, Z.I., Nasierowska-Guttmejer, A., and Ruka, W. (2003). Lymph node status and survival in cutaneous malignant melanoma-sentinel lymph node biopsy impact. Eur. J. Surg. Oncol. 29, 611-618.
37. Salazar-Bookaman, M.M., Fowble, J., Weber, P., and Patil, P.N. (1989). Investigation by NMR spectroscopy of the interaction between synthetic soluble(-)-dopa melanin and drugs. Naunyn Schmiedebergs Arch. Pharmacol. 340, 576-582.
38. Seguin, H., Gardette, D., Moreau, M.F., Madelmont, J.C., and Gramain, J.C. (1998). A general method for the synthesis of N,N′- dialkylaminobutylamines. Synthetic Commun. 28, 4257-4272.
39. Wöll, E., Belikian, A., and Legha, S.S. (1999). Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res. 9, 575-581.
40. Zeise, L., Chedekel, M.R., and Fitzpatrick, T.B. (1995). Melanin: Its Role in Human Photoprotection (Overland Park, KS: Valdenmar Publishing Co.).